Due Diligence Report: GBSN may be the Dark Horse to Win the Race - BrokerBank Securities

In der Downing Street in London residieren die englischen Premierminister. pixabay.com

PR Newswire

NEW YORK, Sept. 14, 2015

NEW YORK, Sept. 14, 2015 /PRNewswire/ -- Great Basin Scientific, Inc. (NASDAQ: GBSN) stock has received a strong recommendation of "buy" from two brokerage firm analysts and "hold" from another. Analysts agreed that the short term price target in GBSN is $8.25, but the stock price can fluctuate by $2.47 according to the standard deviation reading.

The stock price of Great Basin Scientific, Inc. has been severely battered in recent times. The share touched a 52-week high of $9.08 and a low of $0.151 during the same period. On September 8^th, 2015, the share price closed at $0.16, hitting an intraday high of $0.1789 and intraday low of $0.154, with 8979,452 shares being traded.

The share price has dropped more than 95% during the last three-month period. Current market cap of the company hovers around $4.3 million. The percentage of company shares owned by institutional investors is 1.2%.

In a related development, the company disclosed insider buying and selling activities to the Securities Exchange. One of the directors of Great Basin Scientific, Inc., Spafford David, had bought 6,665 shares for a total value of $9,798 on August 21^st, 2015. The company disclosed this information with the SEC in a Form 4 Filing.

Shareholders of GBSN may want to use the following link to be redirected to a due diligence report that will provide critical insight. There is no cost to view full report.

http://bit.ly/_GBSN_Due_Diligence_Report

Copy and paste to browser may be required.

ARIVA.DE Börsen-Geflüster

Kurse

Great Basin Scientific

0,00%

FORWARD-LOOKING DISCLAIMER

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This release and report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this release have not been compensated in any form by any source. A full disclaimer can be found by viewing due diligence. We are only human and may make mistakes. If you notice any errors or omissions, please notify us below.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/due-diligence-report-gbsn-may-be-the-dark-horse-to-win-the-race--brokerbank-securities-300142077.html

SOURCE BrokerBank Securities, Inc.

Mehr Nachrichten zur Great Basin Scientific Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.